213 related articles for article (PubMed ID: 12189383)
41. Targets for active immunotherapy against pediatric solid tumors.
Jacobs JF; Coulie PG; Figdor CG; Adema GJ; de Vries IJ; Hoogerbrugge PM
Cancer Immunol Immunother; 2009 Jun; 58(6):831-41. PubMed ID: 19009292
[TBL] [Abstract][Full Text] [Related]
42. T cell targeted immunotherapy for autoimmune disease.
Lee E; Sinha AA
Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
[TBL] [Abstract][Full Text] [Related]
43. Current approaches in ovarian cancer vaccines.
Reinartz S; Wagner U
Minerva Ginecol; 2004 Dec; 56(6):515-27. PubMed ID: 15729204
[TBL] [Abstract][Full Text] [Related]
44. Current developments in cancer vaccines and cellular immunotherapy.
Ribas A; Butterfield LH; Glaspy JA; Economou JS
J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
[TBL] [Abstract][Full Text] [Related]
45. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
Tacken PJ; de Vries IJ; Torensma R; Figdor CG
Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
[TBL] [Abstract][Full Text] [Related]
46. The immune system and cancer.
Gallucci B
Oncol Nurs Forum; 1987; 14(6 Suppl):3-12. PubMed ID: 3320984
[No Abstract] [Full Text] [Related]
47. CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
Gregor PD; Wolchok JD; Ferrone CR; Buchinshky H; Guevara-Patiño JA; Perales MA; Mortazavi F; Bacich D; Heston W; Latouche JB; Sadelain M; Allison JP; Scher HI; Houghton AN
Vaccine; 2004 Apr; 22(13-14):1700-8. PubMed ID: 15068853
[TBL] [Abstract][Full Text] [Related]
48. [General principles and first clinical trials of therapeutic vaccines against cancer].
Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N
Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413
[TBL] [Abstract][Full Text] [Related]
49. Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Slingluff CL; Chianese-Bullock KA; Bullock TN; Grosh WW; Mullins DW; Nichols L; Olson W; Petroni G; Smolkin M; Engelhard VH
Adv Immunol; 2006; 90():243-95. PubMed ID: 16730266
[TBL] [Abstract][Full Text] [Related]
50. Modulation of antitumor immune responses by hematopoietic cytokines.
Waller EK; Ernstoff MS
Cancer; 2003 Apr; 97(7):1797-809. PubMed ID: 12655538
[TBL] [Abstract][Full Text] [Related]
51. [Cellular immunotherapy as combination partners for the immune checkpoint blockade].
Rössig C
Oncol Res Treat; 2014; 37 Suppl 4():14-5. PubMed ID: 25301192
[No Abstract] [Full Text] [Related]
52. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
53. Can we use monoclonal antibodies to help T cells fight tumors?
Barrett AJ; Wolchok J
Cytotherapy; 2006; 8(1):1-2. PubMed ID: 16627339
[No Abstract] [Full Text] [Related]
54. [Immunotherapy of cancer, using anaerobic corynebacteria].
Halpern B
Acquis Med Recent; 1972; ():95-113. PubMed ID: 4542887
[No Abstract] [Full Text] [Related]
55. Theory of allogeneic reactivity and its relevance to the T-cell response to normal and oncogenic cells.
Lafferty KJ
Adv Pathobiol; 1976; 4():86-97. PubMed ID: 1088247
[No Abstract] [Full Text] [Related]
56. [Tumours and immunity. II. Special part. Tumour antigens. The immune response by neoplasms. Immunotherapy].
Ulvund MJ
Nord Vet Med; 1972; 24(7):380-7. PubMed ID: 4666480
[No Abstract] [Full Text] [Related]
57. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)].
Simó-Camps E; Vich JM; García Calderón PA; Bofill D; Grau A; Anguiz A; Forcadell I
Med Clin (Barc); 1980 May; 74(10):403-7. PubMed ID: 6968012
[No Abstract] [Full Text] [Related]
58. Cancer immunotherapy: Progress and challenges in the clinical setting.
Zarour HM; Ferrone S
Eur J Immunol; 2011 Jun; 41(6):1510-5. PubMed ID: 21618503
[No Abstract] [Full Text] [Related]
59. Evasion of host defences by tumours.
Nelson DS; Nelson M
Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():287-304. PubMed ID: 3315983
[No Abstract] [Full Text] [Related]
60. T cell immunity to tumor antigens.
Hellström I; Hellström KE
Crit Rev Immunol; 1998; 18(1-2):1-6. PubMed ID: 9419443
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
